These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 37247219)

  • 1. Survival, ventricular arrhythmia, and implantable cardioverter-defibrillator usefulness in toxic cardiomyopathy due to substance abuse.
    Dognin N; Rimac G; Domain G; Cinq-Mars A; Massot M; Turgeon PY; Dubois-Sénéchal SM; Bourgault C; Morin J; Bernier M; Beaudoin J; Laflamme M; Charbonneau E; Strubé C; Voisine P; Philippon F; Belzile D; Sénéchal M
    Pacing Clin Electrophysiol; 2023 Jul; 46(7):645-656. PubMed ID: 37247219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary prevention implantable cardioverter-defibrillator use in non-ischemic dilated cardiomyopathy based on arrhythmic risk stratification and left ventricular reverse remodeling prediction.
    Muhammed A; Abdelazeem M; Elewa MG; Sharief M; Ammar A
    Heart Fail Rev; 2023 Jan; 28(1):229-240. PubMed ID: 35587303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of ventricular tachyarrhythmia characteristics in patients with idiopathic dilated or ischemic cardiomyopathy and defibrillators implanted for primary prevention.
    Streitner F; Kuschyk J; Dietrich C; Mahl E; Streitner I; Doesch C; Veltmann C; Schimpf R; Wolpert C; Borggrefe M
    Clin Cardiol; 2011 Oct; 34(10):604-9. PubMed ID: 21887690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implantable cardioverter-defibrillators in lamin A/C mutation carriers with cardiac conduction disorders.
    Anselme F; Moubarak G; Savouré A; Godin B; Borz B; Drouin-Garraud V; Gay A
    Heart Rhythm; 2013 Oct; 10(10):1492-8. PubMed ID: 23811080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Arrhythmia, device interventions and mortality analysis in patients with implanted cardioverter-defibrillator with/without resynchronisation therapy in dilative cardiomyopathy in primary prevention of sudden cardiac death].
    Lelakowski J; Pudło J; Lelakowska-Pieła M; Rydlewska A; Piekarz J; Domaracki D
    Pol Merkur Lekarski; 2016 Apr; 40(238):216-22. PubMed ID: 27137820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Chronic Total Coronary Occlusion on Recurrence of Ventricular Arrhythmias in Ischemic Secondary Prevention Implantable Cardioverter-Defibrillator Recipients (VACTO Secondary Study): Insights From Coronary Angiogram and Electrogram Analysis.
    Nombela-Franco L; Iannaccone M; Anguera I; Amat-Santos IJ; Sanchez-Garcia M; Bautista D; Calvelo MN; Di Marco A; Moretti C; Pozzi R; Scaglione M; Cañadas V; Sandin-Fuentes M; Arenal A; Bagur R; Perez-Castellano N; Fernandez-Perez C; Gaita F; Macaya C; Escaned J; Fernández-Lozano I
    JACC Cardiovasc Interv; 2017 May; 10(9):879-888. PubMed ID: 28473110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left Ventricular Entropy Is a Novel Predictor of Arrhythmic Events in Patients With Dilated Cardiomyopathy Receiving Defibrillators for Primary Prevention.
    Muthalaly RG; Kwong RY; John RM; van der Geest RJ; Tao Q; Schaeffer B; Tanigawa S; Nakamura T; Kaneko K; Tedrow UB; Stevenson WG; Epstein LM; Kapur S; Zei PC; Koplan BA
    JACC Cardiovasc Imaging; 2019 Jul; 12(7 Pt 1):1177-1184. PubMed ID: 30121262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of sleep-disordered breathing to predict occurrence of appropriate and inappropriate implantable-cardioverter defibrillator therapy in patients with implantable cardioverter-defibrillator for primary prevention of sudden cardiac death.
    Kreuz J; Skowasch D; Horlbeck F; Atzinger C; Schrickel JW; Lorenzen H; Nickenig G; Schwab JO
    Am J Cardiol; 2013 May; 111(9):1319-23. PubMed ID: 23411108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial Scar But Not Ischemia Is Associated With Defibrillator Shocks and Sudden Cardiac Death in Stable Patients With Reduced Left Ventricular Ejection Fraction.
    Gupta A; Harrington M; Albert CM; Bajaj NS; Hainer J; Morgan V; Bibbo CF; Bravo PE; Osborne MT; Dorbala S; Blankstein R; Taqueti VR; Bhatt DL; Stevenson WG; Di Carli MF
    JACC Clin Electrophysiol; 2018 Sep; 4(9):1200-1210. PubMed ID: 30236394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic implantable cardioverter defibrillator therapy in dilated cardiomyopathy: impact of left ventricular function.
    Schaer BA; Ammann P; Sticherling C; Zellweger MJ; Cron TA; Osswald S
    Int J Cardiol; 2006 Mar; 108(1):26-30. PubMed ID: 16516695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arrhythmia and Death Following Percutaneous Revascularization in Ischemic Left Ventricular Dysfunction: Prespecified Analyses From the REVIVED-BCIS2 Trial.
    Perera D; Morgan HP; Ryan M; Dodd M; Clayton T; O'Kane PD; Greenwood JP; Walsh SJ; Weerackody R; McDiarmid A; Amin-Youssef G; Strange J; Modi B; Lockie T; Hogrefe K; Ahmed FZ; Behan M; Jenkins N; Abdelaal E; Anderson M; Watkins S; Evans R; Rinaldi CA; Petrie MC;
    Circulation; 2023 Sep; 148(11):862-871. PubMed ID: 37555345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The need to modify patient selection to improve the benefits of implantable cardioverter-defibrillator for primary prevention of sudden death in non-ischaemic dilated cardiomyopathy.
    Disertori M; Quintarelli S; Mazzola S; Favalli V; Narula N; Arbustini E
    Europace; 2013 Dec; 15(12):1693-701. PubMed ID: 23946316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardioverter-defibrillator does not improve short-term survival among patients with non-ischemic cardiomyopathy and reduced left ventricular ejection fraction.
    Jilek C; Lewalter T; Pauschinger M; von Scheidt W; Frankenstein L; Pfister O; Hambrecht R; Bruder O; Brachmann J; Hartmann A; Strasser R; Hochadel M; Senges J
    Clin Res Cardiol; 2020 Jan; 109(1):115-123. PubMed ID: 31236690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricular function improvement after prophylactic implantable cardioverter-defibrillator implantation in patients with non-ischaemic dilated cardiomyopathy.
    Grimm W; Timmesfeld N; Efimova E
    Europace; 2013 Nov; 15(11):1594-600. PubMed ID: 23639855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal Arrhythmic Risk Assessment Based on Ejection Fraction in Patients with Recent-Onset Nonischemic Dilated Cardiomyopathy.
    De Angelis G; Merlo M; Barbati G; Bertolo S; De Luca A; Ramani F; Adamo L; Sinagra G
    J Am Soc Echocardiogr; 2022 Aug; 35(8):801-809.e3. PubMed ID: 35367610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic Review for the 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.
    Kusumoto FM; Bailey KR; Chaouki AS; Deshmukh AJ; Gautam S; Kim RJ; Kramer DB; Lambrakos LK; Nasser NH; Sorajja D
    J Am Coll Cardiol; 2018 Oct; 72(14):1653-1676. PubMed ID: 29097297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of implantable cardioverter defibrillator on the prognosis of nonischemic dilated cardiomyopathy patients compared with standard medical treatments.
    Salehi Omran H; Naghashzadeh F; Irilouzadian R; Dolatshahi S; Hedayati Goudarzi MT; Salehi Omran MT
    Clin Cardiol; 2023 Jun; 46(6):674-679. PubMed ID: 37057368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac Magnetic Resonance for Prophylactic Implantable-Cardioverter Defibrillator Therapy in Ischemic Cardiomyopathy: The DERIVATE-ICM International Registry.
    Pontone G; Guaricci AI; Fusini L; Baggiano A; Guglielmo M; Muscogiuri G; Volpe A; Abete R; Aquaro G; Barison A; Bogaert J; Camastra G; Carigi S; Carrabba N; Casavecchia G; Censi S; Cicala G; De Cecco CN; De Lazzari M; Di Giovine G; Di Roma M; Dobrovie M; Focardi M; Gaibazzi N; Gismondi A; Gravina M; Lanzillo C; Lombardi M; Lorenzoni V; Lozano-Torres J; Martini C; Marzo F; Masi A; Memeo R; Moro C; Nese A; Palumbo A; Pavon AG; Pedrotti P; Marra MP; Pica S; Pradella S; Presicci C; Rabbat MG; Raineri C; Rodriguez-Palomares JF; Sbarbati S; Schoepf UJ; Squeri A; Sverzellati N; Symons R; Tat E; Timpani M; Todiere G; Valentini A; Varga-Szemes A; Masci PG; Schwitter J
    JACC Cardiovasc Imaging; 2023 Nov; 16(11):1387-1400. PubMed ID: 37227329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.